Rechtin James A. 4

4 · HUMANA INC · Filed May 5, 2026

AI-generated summary of this filing

Updated May 5, 2026

Humana (HUM) CEO James Rechtin Receives 35,633-Share Award

What Happened

James A. Rechtin, President & CEO of Humana Inc. (HUM), received an award of 35,633 shares on 2026-05-01. The grant is reported at $0.00 per share (code A) and represents restricted stock units (RSUs)/contingent rights to receive shares under Humana’s stock incentive plans. This is a grant/award—not a purchase or sale—so no immediate cash transaction or proceeds were reported.

Key Details

Transaction date: 2026-05-01; Form 4 filed: 2026-05-05 (filing appears timely).
Transaction type/code: Award/Grant (A); price reported: $0.00.
Shares granted: 35,633 restricted stock units (contingent right to receive one share per RSU).
Shares owned after transaction: Not specified in the filing.
Relevant footnotes:
- F4/F5/F6: These awards are RSUs under Humana’s 2019 Amended & Restated Stock Incentive Plan (and 2026 Stock Incentive Plan); RSUs are contingent rights exempt under Rule 16b-3(d)(1)&(3).
- F5/F6 reference prior RSU grants and vesting schedules (e.g., earlier 1/8/2024 grants vesting in three annual installments).
- F1: Some shares are held in revocable trusts for the reporting person and spouse, with the reporting person as a trustee.
No tax-withholding sale or immediate cashless disposition is indicated in this filing.

Context

RSUs are a common form of executive compensation: they represent the right to receive shares in the future, typically subject to vesting conditions and therefore do not reflect an immediate purchase or sale of stock.
Because this is an award, it is not an indicator of immediate insider selling or buying—investors should watch vesting schedules and future filings for when shares are delivered or sold.

Form 4

Period: 2026-05-01

President & CEO

Transactions

Award
Humana Common
[F6][F1]
2026-05-01+35,633→ 63,938 total(indirect: See Footnote)

Holdings

Options
[F2]
Exercise: $458.19Exp: 2031-01-08→ Humana Common (29,230 underlying)
29,230
Options
[F3]
Exercise: $367.21Exp: 2031-02-21→ Humana Common (15,772 underlying)
15,772
Restricted Stock Units
[F4][F5]
→ Humana Common (2,183 underlying)
2,183

Footnotes (6)

[F1]All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.
[F2]Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27.
[F3]Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
[F4]Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
[F5]Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27.
[F6]Includes 49,687 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

Signature

James A. Rechtin|2026-05-05

1 file